Cargando…

Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism

The present study observed the effect of baicalin on blood glucose and renal function in patients with diabetic nephropathy and explored its mechanism of action. A total of 95 patients diagnosed with diabetic nephropathy by clinical and laboratory examinations were selected and randomly divided into...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Mingzheng, Kan, Lin, Wu, Lianye, Zhu, Yingchun, Wang, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396004/
https://www.ncbi.nlm.nih.gov/pubmed/30867693
http://dx.doi.org/10.3892/etm.2019.7181
_version_ 1783399184106258432
author Yang, Mingzheng
Kan, Lin
Wu, Lianye
Zhu, Yingchun
Wang, Qing
author_facet Yang, Mingzheng
Kan, Lin
Wu, Lianye
Zhu, Yingchun
Wang, Qing
author_sort Yang, Mingzheng
collection PubMed
description The present study observed the effect of baicalin on blood glucose and renal function in patients with diabetic nephropathy and explored its mechanism of action. A total of 95 patients diagnosed with diabetic nephropathy by clinical and laboratory examinations were selected and randomly divided into a control and treatment group. The control group included 45 patients who were treated with routine symptomatic treatment. The remaining 50 patients in the treatment group received baicalin, in addition to routine symptomatic treatment. The treatment course was 6 months. Following this, the changes of indicators such as fasting plasma glucose (FPG), glycosylated hemoglobin (HBA1c), aldose reductase (AR) activity, 24-h urinary microalbumin, urinary β2-microglobulin (β2-MG) and urinary albumin excretion rate (UAER) were compared before and after treatment; at the same time, the variations of indexes, including superoxide dismutase (SOD), glutathione peroxidase (GSH-px), nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB), transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF) were detected. Compared with those in the control group, baicalin had little effect on the treatment group's FPG and HBA1c, but it clearly reduced the AR activity and the difference was significant (P<0.05). Baicalin visibly decreased the 24-h urinary microalbumin, urinary β2-MG and UAER (P<0.05) and had notable effect on improving renal function. Following treatment, compared with those in the control group, baicalin distinctly increased the levels of SOD and GSH-px (P<0.05) and decreased the content of NF-κB and VEGF (P<0.05), however, its impact on the expression of TGF-β1 was not statistically significant (P>0.05). The results showed that baicalin may improve the renal function in patients with diabetic nephropathy and delay the progression of diabetic nephropathy through various ways, including anti-inflammation and anti-oxidation.
format Online
Article
Text
id pubmed-6396004
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-63960042019-03-13 Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism Yang, Mingzheng Kan, Lin Wu, Lianye Zhu, Yingchun Wang, Qing Exp Ther Med Articles The present study observed the effect of baicalin on blood glucose and renal function in patients with diabetic nephropathy and explored its mechanism of action. A total of 95 patients diagnosed with diabetic nephropathy by clinical and laboratory examinations were selected and randomly divided into a control and treatment group. The control group included 45 patients who were treated with routine symptomatic treatment. The remaining 50 patients in the treatment group received baicalin, in addition to routine symptomatic treatment. The treatment course was 6 months. Following this, the changes of indicators such as fasting plasma glucose (FPG), glycosylated hemoglobin (HBA1c), aldose reductase (AR) activity, 24-h urinary microalbumin, urinary β2-microglobulin (β2-MG) and urinary albumin excretion rate (UAER) were compared before and after treatment; at the same time, the variations of indexes, including superoxide dismutase (SOD), glutathione peroxidase (GSH-px), nuclear factor κ-light-chain-enhancer of activated B cells (NF-κB), transforming growth factor-β1 (TGF-β1) and vascular endothelial growth factor (VEGF) were detected. Compared with those in the control group, baicalin had little effect on the treatment group's FPG and HBA1c, but it clearly reduced the AR activity and the difference was significant (P<0.05). Baicalin visibly decreased the 24-h urinary microalbumin, urinary β2-MG and UAER (P<0.05) and had notable effect on improving renal function. Following treatment, compared with those in the control group, baicalin distinctly increased the levels of SOD and GSH-px (P<0.05) and decreased the content of NF-κB and VEGF (P<0.05), however, its impact on the expression of TGF-β1 was not statistically significant (P>0.05). The results showed that baicalin may improve the renal function in patients with diabetic nephropathy and delay the progression of diabetic nephropathy through various ways, including anti-inflammation and anti-oxidation. D.A. Spandidos 2019-03 2019-01-17 /pmc/articles/PMC6396004/ /pubmed/30867693 http://dx.doi.org/10.3892/etm.2019.7181 Text en Copyright: © Yang et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Yang, Mingzheng
Kan, Lin
Wu, Lianye
Zhu, Yingchun
Wang, Qing
Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism
title Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism
title_full Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism
title_fullStr Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism
title_full_unstemmed Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism
title_short Effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism
title_sort effect of baicalin on renal function in patients with diabetic nephropathy and its therapeutic mechanism
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6396004/
https://www.ncbi.nlm.nih.gov/pubmed/30867693
http://dx.doi.org/10.3892/etm.2019.7181
work_keys_str_mv AT yangmingzheng effectofbaicalinonrenalfunctioninpatientswithdiabeticnephropathyanditstherapeuticmechanism
AT kanlin effectofbaicalinonrenalfunctioninpatientswithdiabeticnephropathyanditstherapeuticmechanism
AT wulianye effectofbaicalinonrenalfunctioninpatientswithdiabeticnephropathyanditstherapeuticmechanism
AT zhuyingchun effectofbaicalinonrenalfunctioninpatientswithdiabeticnephropathyanditstherapeuticmechanism
AT wangqing effectofbaicalinonrenalfunctioninpatientswithdiabeticnephropathyanditstherapeuticmechanism